Indies Pharma Jamaica Limited reported earnings results for the third quarter and nine months ended July 31, 2023. For the third quarter, the company reported sales was JMD 299.74 million compared to JMD 264.74 million a year ago. Net income was JMD 84.29 million compared to JMD 72.76 million a year ago. Basic earnings per share from continuing operations was JMD 0.06 compared to JMD 0.05 a year ago.
For the nine months, sales was JMD 786.9 million compared to JMD 727.63 million a year ago. Net income was JMD 173.21 million compared to JMD 187.71 million a year ago. Basic earnings per share from continuing operations was JMD 0.13 compared to JMD 0.14 a year ago.